in pictures and a few words
What it is and why it matters
The gut wall separates what is inside the gut — bacteria, food leftovers — from the rest of the body. When it lets through more than it should, people speak of a “leaky gut”.
- It is the largest border between the body and the outside world
- It is held by a mucus layer, tightly joined cells and the immune cells beneath them
- It is not a separate diagnosis but a process linked to a number of diseases
A protein that opens the “clasps”
The cells of the wall are joined by protein “clasps”. The protein zonulin can loosen them — and then the wall lets more through.
- Zonulin release is triggered by a wheat protein — in people with an inherited tendency
- Some gut bacteria trigger it too
- Blood zonulin can be higher in coeliac disease, type 1 diabetes, rheumatoid arthritis
What may weaken the wall
The main cause is a disturbed mix of gut bacteria: fewer of those that make butyrate, the fuel for colon cells. Food, medicines and stress also play a part.
- Sugar, alcohol, food emulsifiers; gluten — with an inherited tendency
- Ibuprofen, diclofenac and similar, antibiotics, long-term omeprazole and similar
- Long-term stress: the stress hormone loosens the “clasps” between cells
The link with autoimmune diseases
In an autoimmune disease, the body’s defences attack its own tissues. According to one model, it needs three conditions at once, and one of them is a weakened gut wall.
- The other two are an inherited tendency and an outside push: infection, gluten or a toxin
- That is why not everyone with these genes gets ill
- Strengthening the wall may slow or stop the course of the disease
Which tests are used
The main test is the protein zonulin in the blood. Calprotectin in stool shows whether there is inflammation in the gut. Together they give the fullest picture.
- Coeliac tests are done before going gluten-free — otherwise the result may mislead
- Bloating, heaviness after meals, long-lasting diarrhoea — a breath test for bacteria in the small intestine
- Calprotectin above 250 µg/g — first a colonoscopy with biopsy
Food: what to add and what to drop
Foods that support the wall are added, and those that weaken it are dropped for a while. Without coeliac disease or an inherited tendency, gluten can be brought back after recovery.
- Bone broth, fermented foods, oily fish, berries, turmeric
- Vegetables with fibre — artichoke, asparagus, onion; 25–35 g of fibre a day in total
- For at least 4–8 weeks — no gluten, sugar, alcohol or foods with emulsifiers
Good bacteria — in their turn
Good bacteria are added with probiotics and fermented foods: sauerkraut, kimchi, kefir, kombucha. Their food is prebiotics, such as inulin.
- Mixes of several kinds of bacteria are used
- In studies, probiotics lowered zonulin
- With bacterial overgrowth in the small intestine, probiotics before treatment may worsen symptoms
What to feed the wall with
The wall is fed with glutamine, zinc carnosine, butyrate, vitamin D, omega-3, collagen or bone broth.
- Glutamine is an amino acid, the main fuel of wall cells: 5–10 g a day on an empty stomach
- Vitamin D: the dose is chosen by a blood test, rechecked after 8–12 weeks
- Zinc for more than 2 months — with a blood copper check: zinc hinders its absorption
Who should see a doctor first
Any recovery programme needs a doctor’s advice first — especially in these cases and if you take blood thinners: with them, large doses of omega-3 only if your doctor agrees.
- Poor liver function or cancer now — no glutamine; weak kidneys — a lower dose
- No probiotics: low white blood cells, a transplanted organ, a central catheter, severe pancreatitis
- Ibuprofen and similar, omeprazole and similar — don’t stop or change them yourself, only with a doctor
Important. Blood in the stool, noticeable weight loss, diarrhoea at night, anaemia, symptoms starting after 50, colon cancer in relatives — get checked first.
In one sentence
The gut wall is supported with food, good bacteria and nourishment — it takes months, not days. Start with a check-up so as not to miss other diseases.
From "Myth" to Recognized Pathology
For decades, "leaky gut" was dismissed by mainstream medicine as pseudoscience. That changed with the discovery of zonulin — a protein that regulates tight junctions between intestinal epithelial cells — by Professor Alessio Fasano at Harvard Medical School. His landmark publication in The Lancet (2000) and subsequent review in Physiological Reviews (2011) established a direct link between intestinal barrier dysfunction and autoimmune disease development.
Today, increased intestinal permeability is recognized as a pathophysiological factor in celiac disease, type 1 diabetes, inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, and numerous other conditions. A meta-analysis in Gut (2020) confirmed that markers of intestinal permeability are elevated 3-5 fold in patients with autoimmune diseases compared to healthy controls.
Anatomy of the Intestinal Barrier
The intestinal barrier is a multi-layered defense system separating gut contents — bacteria, toxins, undigested food antigens — from the body's internal environment. The intestinal surface area is approximately 32 square meters (Nature, 2014), making it the largest interface between the body and the external world.
The barrier comprises several layers: a mucus layer (mucins, secretory IgA, antimicrobial peptides called defensins); a monolayer of epithelial cells (enterocytes) connected by tight junctions; and the gut-associated lymphoid tissue (GALT), which houses approximately 70% of the body's immune cells.
Tight junctions are the critical barrier component. They consist of the transmembrane proteins occludin and claudins (27 types) and the associated intracellular zonula occludens proteins (ZO-1, ZO-2, ZO-3), which anchor the junction to the cytoskeleton. These proteins form a network controlling paracellular transport — the passage of substances between cells.
Zonulin: The Key to Understanding Leaky Gut
Zonulin is the only known physiological regulator of intestinal tight junctions. Fasano's discovery (2000) showed that zonulin modulates permeability by interacting with receptors on the apical surface of enterocytes, triggering intracellular signaling through protein kinase C (PKC) and leading to tight junction disassembly.
Two primary triggers of zonulin release: 1) gliadin (wheat protein) — in genetically susceptible individuals causes massive zonulin release, explaining celiac disease pathogenesis; 2) gram-negative bacteria — their lipopolysaccharides (LPS) contacting intestinal epithelium also activate the zonulin pathway.
Elevated serum zonulin has been found in: celiac disease (5-10 fold), type 1 diabetes (3-4 fold), rheumatoid arthritis (2-3 fold), inflammatory bowel disease (2-4 fold), obesity and metabolic syndrome (1.5-2 fold).
Causes of Increased Intestinal Permeability
Gut Dysbiosis
Microbial imbalance is the leading cause. Reduced butyrate-producing bacteria (Faecalibacterium prausnitzii, Roseburia) leads to butyrate deficiency — the primary energy source for colonocytes and a key tight junction regulator. A meta-analysis in Microbiome (2021) showed dysbiosis precedes autoimmune disease development by 3-5 years on average.
Dietary Factors
- Gluten — in genetically predisposed individuals (HLA-DQ2/DQ8) causes zonulin-mediated barrier disruption
- Refined sugar — promotes pathogenic flora growth and reduces microbiome diversity
- Food additives (emulsifiers E433, E466) — a Nature (2015) study showed direct damage to the mucin layer
- Alcohol — disrupts expression of tight junction proteins (occludin, ZO-1)
Medications
- NSAIDs (ibuprofen, diclofenac) — increase permeability through COX inhibition and direct mucosal damage
- Proton pump inhibitors — long-term use is associated with dysbiosis and increased permeability
- Antibiotics — especially broad-spectrum: a single course can disrupt the microbiome for 6-12 months
Chronic Stress
Cortisol-induced degradation of tight junctions through the gut-brain axis. A study in Psychoneuroendocrinology (2019) showed chronic psychological stress increases intestinal permeability by 40-60%, measured by the lactulose/mannitol ratio.
The Fasano Triad: Leaky Gut and Autoimmunity
Professor Fasano proposed a model requiring three simultaneous components for autoimmune disease development: 1) genetic predisposition (HLA genes), 2) an environmental trigger (infection, gluten, toxin), 3) increased intestinal permeability allowing antigens to reach the submucosal immune system.
This model explains why not all carriers of susceptibility genes develop disease: without barrier disruption, the trigger cannot reach immune cells. A review in the Journal of Autoimmunity (2019) confirms that restoring the intestinal barrier may slow or prevent autoimmune disease progression.
Diagnostic Testing
Serum Zonulin — considered the most specific marker, but commercial ELISA kits may also react with other proteins. Normal range: <48 ng/mL (ELISA). Elevation correlates with the degree of barrier dysfunction.
Lactulose/Mannitol Test — the classic functional test. The patient drinks a solution of lactulose (large molecule) and mannitol (small molecule), then their ratio in urine is measured. An elevated ratio indicates paracellular leakage.
Anti-LPS Antibodies (anti-LPS IgG/IgM) — marker of bacterial endotoxin translocation through the damaged barrier.
Fecal Calprotectin — marker of intestinal inflammation. Normal: <50 mcg/g. Elevation indicates active mucosal inflammation.
I-FABP (Intestinal Fatty Acid-Binding Protein) — marker of enterocyte damage. Rises with acute intestinal epithelial destruction.
| Marker | Reference |
|---|---|
| Serum zonulin | <48 ng/mL |
| Fecal calprotectin | <50 mcg/g |
| Lactulose/mannitol | urine ratio |
| Anti-LPS IgG/IgM | endotoxin translocation |
| I-FABP | enterocyte damage |
The 4R Restoration Protocol
Phase 1: Remove (2-4 weeks)
- Eliminate provocative factors: gluten, refined sugar, alcohol, emulsifiers
- Eradicate pathogenic flora (if confirmed dysbiosis): berberine 500 mg twice daily or oregano oil
- Review medications: replace NSAIDs, minimize PPIs
- Stress management: meditation, breathwork
Phase 2: Replace (4-8 weeks)
- Digestive enzymes if insufficient: pancreatin, HCl (if hypochlorhydric)
- Bile acids for impaired fat metabolism (UDCA)
- Fiber: 25-35 g/day from diverse sources
Phase 3: Reinoculate (8-12 weeks)
- Probiotics: multi-strain formulas (Lactobacillus rhamnosus GG, L. plantarum 299v, Bifidobacterium lactis, Saccharomyces boulardii). Meta-analysis in Nutrients (2021): probiotics reduce zonulin by 15-25%
- Prebiotics: FOS, GOS, inulin — substrate for beneficial flora growth
- Fermented foods: sauerkraut, kimchi, kefir, kombucha
Phase 4: Repair (8-16 weeks)
- L-Glutamine: 5-10 g/day on empty stomach — primary energy source for enterocytes. RCT in Clinical Nutrition (2019): 5 g/day for 8 weeks reduced permeability by 30%
- Zinc Carnosine: 75-150 mg/day — stabilizes enterocyte membranes and stimulates regeneration
- Sodium Butyrate: 300-600 mg/day — key colonocyte metabolite, strengthens tight junctions
- Vitamin D: 2,000-5,000 IU/day — regulates tight junction protein expression
- Omega-3 Fatty Acids: 2-3 g EPA+DHA/day — anti-inflammatory action
- Collagen/Bone Broth: source of glycine and proline for mucosal regeneration
A close look at one glutamine supplement — its composition, doses compared with the studies, and who should not take it: RepairGut: what is inside and who it suits.
Dietary Guidelines
Frequently Asked Questions
Is leaky gut a real diagnosis? Increased intestinal permeability is a scientifically validated pathophysiological process described in hundreds of peer-reviewed publications. While there is no separate ICD-10 code, the mechanism is recognized as a key factor in autoimmune pathology.
How long does barrier restoration take? For uncomplicated cases: 3-6 months. For autoimmune conditions: 6-12 months or more. Enterocytes regenerate every 3-5 days, but full mucosal architecture restoration requires significantly more time.
Do I need to avoid gluten permanently? Not necessarily. In individuals without celiac disease and without genetic predisposition (HLA-DQ2/DQ8 negative), gluten may be reintroduced after barrier restoration. Follow-up zonulin testing helps assess readiness.
Which test is most informative? Serum zonulin is considered the most specific marker, but commercial ELISA kits may also react with other proteins. Fecal calprotectin additionally assesses the degree of inflammation. The combination of both tests provides the most complete picture.
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment protocol.
🌀
Reference Ranges and Methodological Limits of Permeability Testing
The article enumerates serum zonulin, the lactulose/mannitol (L/M) ratio, fecal calprotectin, anti-LPS antibodies, and intestinal fatty acid-binding protein (I-FABP) without specifying decision thresholds. In clinical use these values are not interchangeable, and several have non-trivial assay caveats.
Serum zonulin measured by ELISA is raised across the celiac spectrum: in dermatitis herpetiformis, the skin form of celiac disease, 14 of 16 patients (87.5%) had abnormally increased values PMID: 15822038. However, independent biochemical characterization has shown that the antibody used in widely sold zonulin ELISA kits cross-reacts with proteins other than pre-haptoglobin-2, so an isolated "elevated zonulin" should be interpreted as a permeability signal rather than as a direct quantification of the zonulin molecule PMID: 30640940. Serial measurement in the same patient on the same assay platform is more informative than a single absolute value.
The lactulose/mannitol urinary recovery test remains the historical gold standard. Cut-offs are laboratory-specific and HPLC methodology varies: in one validation study, an L/M ratio above 0.022 identified Crohn's disease (sensitivity 89.5%, specificity 100%) and above 0.018 liver cirrhosis (sensitivity 84.2%, specificity 88.5%) PMID: 18320320. Diabetic, NSAID-exposed, and IBS-D cohorts consistently show ratios shifted upward versus controls. The test is non-invasive but requires standardized fasting, fixed sugar doses, and complete 5-hour urine collection; incomplete collection is the most common preanalytical error.
Fecal calprotectin separates functional from organic disease: values below 50 µg/g effectively exclude active mucosal inflammation, 50–250 µg/g is an indeterminate zone that warrants repeat testing or imaging, and values above 250 µg/g are strongly associated with active IBD PMID: 30828114. Calprotectin is sensitive to neutrophil traffic, not to junctional permeability per se, so a normal value does not exclude leaky gut — it excludes neutrophilic inflammation.
I-FABP, released from damaged enterocytes, is the most specific marker for epithelial injury but degrades quickly and requires careful sample handling. There is no consensus single cutoff; values are interpreted relative to laboratory-specific controls and trended within the same patient. The clinical takeaway: no single biomarker is diagnostic, and a 2-marker panel (zonulin or L/M plus calprotectin) is more defensible than any number in isolation.
🌀
Dosing Protocols for the 4R Repair Phase
The article lists L-glutamine, zinc carnosine, butyrate, vitamin D, omega-3, and collagen without amounts or duration. Published protocols used in human studies are as follows.
L-glutamine: in a randomized trial in post-infectious IBS-D, oral L-glutamine 5 g three times daily for 8 weeks reduced the L/M permeability ratio and IBS-SSS score versus placebo, with no serious adverse events PMID: 30108163. Lower maintenance doses (5 g once daily) are used in clinical practice for ongoing barrier support. Glutamine is contraindicated in hepatic encephalopathy, severe renal impairment, and in patients with active malignancy where amino acid loading is unwanted; it should be paused during acute illness with hyperammonemia.
Zinc-L-carnosine (polaprezinc): the most studied regimen is 75 mg twice daily (containing 17 mg elemental zinc per dose); in a randomized crossover trial in 10 healthy volunteers, zinc carnosine prevented the threefold rise in small-bowel permeability caused by 5 days of indomethacin, and in rodent models it reduced gastric and small-intestinal injury PMID: 16777920. Long courses risk copper deficiency; if treatment exceeds 8 weeks, periodic plasma zinc and copper should be checked.
Butyrate: oral sodium or tributyrin formulations 300–600 mg/day support colonocyte energy supply and tight junction expression in mechanistic studies. Direct outcome trials on permeability are limited; dietary fermentable fiber (resistant starch, inulin) remains the more physiological butyrate source for patients tolerating it.
Vitamin D: 1,25(OH)2D up-regulates ZO-1, claudin-1, and occludin in intestinal epithelium PMID: 17962355. Aim for serum 25-OH-D of 40–60 ng/mL (100–150 nmol/L); typical replacement is 2,000–5,000 IU cholecalciferol daily titrated to level, with retest at 8–12 weeks.
Akkermansia muciniphila and Saccharomyces boulardii are the two probiotic agents with the strongest mucus-layer and tight-junction data in humans and animals; both have been shown to restore barrier function in metabolic and post-antibiotic settings PMID: 32917747, PMID: 38004116. Duration is typically 8–12 weeks before reassessment. Live Akkermansia is contraindicated in severely immunocompromised patients.
🌀
Drug-Induced Barrier Injury: Time Course and Recovery
The article names NSAIDs and PPIs as triggers without quantifying exposure or recovery windows, which is the practical question patients ask.
NSAIDs increase small-intestinal permeability, and among patients on long-term therapy small-bowel inflammation (by indium-111 white-cell faecal excretion) was found in 54–72% of those taking conventional NSAIDs PMID: 9824578. The mechanism is biphasic: topical uncoupling of mitochondrial oxidative phosphorylation in enterocytes, followed by COX-mediated loss of prostaglandin-dependent mucus and bicarbonate. Selective COX-2 inhibitors reduce, but do not eliminate, this small-bowel injury. After NSAID withdrawal, permeability normalizes over 2–6 weeks in the absence of structural ulcers. Practical implication: a 4R protocol initiated while NSAIDs continue is unlikely to produce durable benefit.
Proton pump inhibitors alter the upstream environment in two ways relevant to permeability: gastric hypochlorhydria permits oral flora to colonize the small bowel, and PPI exposure is independently associated with reduced microbial diversity, expansion of Streptococcaceae and Enterococcaceae, and depletion of butyrate-producing taxa PMID: 26657899. Dysbiosis from PPIs typically becomes detectable within 4–8 weeks of continuous use and partially reverses 4–8 weeks after discontinuation. Indications should be reviewed at every visit; long-term PPI use without documented Barrett, severe erosive esophagitis, or NSAID gastroprotection is rarely justified.
Antibiotic-induced dysbiosis is dose- and class-dependent; broad-spectrum cycles (amoxicillin-clavulanate, fluoroquinolones, clindamycin) shift the microbiome for 6–12 months, and complete recovery is not guaranteed.
🌀
Larazotide Acetate: What Zonulin Antagonism Has and Has Not Shown
Because zonulin is the article's mechanistic centerpiece, it is reasonable to ask whether pharmacological blockade of the zonulin pathway translates into clinical benefit. Larazotide acetate is an oral, non-absorbed octapeptide that antagonizes zonulin-mediated tight-junction opening. In a phase 2b randomized trial in celiac patients on a gluten-free diet with persistent symptoms, larazotide 0.5 mg three times daily reduced symptom days versus placebo, while higher doses paradoxically did not PMID: 25683116. A subsequent phase 3 trial did not meet its primary endpoint, and the FDA has not approved larazotide for any indication. The clinical lesson is twofold: first, the zonulin pathway is biologically real and pharmacologically addressable; second, closing tight junctions in isolation does not reliably overcome the upstream antigenic and inflammatory drive in autoimmune disease. This is consistent with the Fasano triad model — removing the trigger (gluten in celiac) remains the dominant therapeutic lever, and barrier modulation is adjunctive rather than curative.
🌀
Dietary Protocols Beyond Gluten and Sugar: Low-FODMAP Evidence
The article's dietary section emphasizes gluten, refined sugar, and additive avoidance but does not address fermentable carbohydrate load, which is the most rigorously studied dietary lever in IBS-overlap leaky-gut phenotypes. A low-FODMAP diet (restriction of fermentable oligo-, di-, monosaccharides, and polyols for 4–6 weeks followed by structured reintroduction) reduces small-bowel water load, luminal distension, and symptom burden in roughly 50–75% of IBS patients across randomized trials, with parallel reductions in lactulose/mannitol ratio and serum LPS-binding protein in subsets PMID: 38337655. The diet is a diagnostic tool, not a chronic prescription: reintroduction is mandatory, since prolonged restriction depletes bifidobacteria and butyrate-producing taxa. Patients with eating-disorder history should not undertake low-FODMAP without dietetic supervision.
References
- PMID: 15822038. PMID 15822038
- PMID: 30640940. PMID 30640940
- PMID: 18320320. PMID 18320320
- PMID: 30828114. PMID 30828114
- PMID: 30108163. PMID 30108163
- PMID: 16777920. PMID 16777920
- PMID: 17962355. PMID 17962355
- PMID: 32917747. PMID 32917747
- PMID: 38004116. PMID 38004116
- PMID: 9824578. PMID 9824578
- PMID: 26657899. PMID 26657899
- PMID: 25683116. PMID 25683116
- PMID: 38337655. PMID 38337655
Key facts
- Zonulin is the only known physiological regulator of intestinal tight junctions (discovered by Fasano, 2000).
- The intestinal surface area is about 32 square meters — the largest interface between body and environment (Nature, 2014).
- The Fasano triad requires three components for autoimmunity: genetic predisposition, an environmental trigger, and increased permeability.
- Serum zonulin normal range is <48 ng/mL (ELISA); fecal calprotectin normal is <50 mcg/g.
- The 4R protocol — Remove, Replace, Reinoculate, Repair — restores the intestinal barrier in phases.




